How are ADMA long call max profit and max loss calculated?

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ADMA long call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 54.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$52.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a ADMA long call?

The breakeven for the ADMA long call priced on this page is roughly $9.53 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ADMA market-implied 1-standard-deviation expected move in the same options snapshot is approximately 15.51%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current ADMA implied volatility affect this long call?

ADMA ATM IV is at 54.10% with IV rank near 6.75%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

ADMA Long Call Strategy

ADMA (ADMA Biologics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

ADMA Biologics, Inc. functions as a biopharmaceutical company specializing in the development, manufacturing, and commercialization of advanced biologic therapies derived from blood plasma. These specialized products are engineered to address immune system disorders and infectious diseases, catering to markets across the United States and internationally. Their current product portfolio includes BIVIGAM and ASCENIV, both intravenous immune globulin (IVIG) treatments prescribed for primary humoral immunodeficiency (PI). Additionally, the company offers Nabi-HB, utilized for immediate treatment following acute exposure to the Hepatitis B virus and other specified exposures. Beyond its existing offerings, ADMA is actively developing a pipeline of new plasma-derived therapeutics. This includes immunoglobulin products specifically targeting the prevention and treatment of S. pneumonia infections.

ADMA (ADMA Biologics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $2.19B, a trailing P/E of 12.79, a beta of 0.77 versus the broader market, a 52-week range of 7.21-20.458, average daily share volume of 4.5M, a public-listing history dating back to 2013, approximately 644 full-time employees. These structural characteristics shape how ADMA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.77 places ADMA roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a long call on ADMA?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

ADMA snapshot

As of August 14, 2026, spot at $9.45, ATM IV 54.10%, IV rank 6.75%, expected move 15.51%. The long call on ADMA below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 7-day expiry.

Why this long call structure on ADMA specifically: ADMA IV at 54.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a ADMA long call, with a market-implied 1-standard-deviation move of approximately 15.51% (roughly $1.47 on the underlying). The 7-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ADMA expiries trade a higher absolute premium for lower per-day decay. Position sizing on ADMA should anchor to the underlying notional of $9.45 per share and to the trader's directional view on ADMA stock.

ADMA long call setup

The ADMA long call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ADMA at $9.45 on that close, the first option leg uses a $9.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ADMA chain at a 7-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ADMA shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$9.00	$0.53

ADMA long call risk and reward

Net Premium / Debit: -$52.50
Max Profit (per contract): Unbounded
Max Loss (per contract): -$52.50
Breakeven(s): $9.53
Risk / Reward Ratio: Unbounded

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

ADMA long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on ADMA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.9%	-$52.50
$2.10	-77.8%	-$52.50
$4.19	-55.7%	-$52.50
$6.28	-33.6%	-$52.50
$8.36	-11.5%	-$52.50
$10.45	+10.6%	+$92.67
$12.54	+32.7%	+$301.51
$14.63	+54.8%	+$510.34
$16.72	+76.9%	+$719.17
$18.81	+99.0%	+$928.01

When traders use long call on ADMA

Long calls on ADMA express a bullish thesis with defined risk; traders use them ahead of ADMA catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

ADMA thesis for this long call

The market-implied 1-standard-deviation range for ADMA extends from approximately $7.98 on the downside to $10.92 on the upside. A ADMA long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ADMA IV rank near 6.75% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ADMA at 54.10%. As a Healthcare name, ADMA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ADMA-specific events.

ADMA long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ADMA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ADMA alongside the broader basket even when ADMA-specific fundamentals are unchanged. Long-premium structures like a long call on ADMA are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ADMA chain quotes before placing a trade.

Frequently asked questions

What is a long call on ADMA?: A long call on ADMA is the long call strategy applied to ADMA (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ADMA stock at $9.45 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed ADMA chain strike and the premiums come straight from that session's bid/ask midpoint.
How are ADMA long call max profit and max loss calculated?: Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ADMA long call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 54.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$52.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ADMA long call?: The breakeven for the ADMA long call priced on this page is roughly $9.53 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The ADMA market-implied 1-standard-deviation expected move in the same options snapshot is approximately 15.51%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on ADMA?: Long calls on ADMA express a bullish thesis with defined risk; traders use them ahead of ADMA catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current ADMA implied volatility affect this long call?: ADMA ATM IV is at 54.10% with IV rank near 6.75%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.